Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Anti-aggregating effect of BAY 58-2667, an activator of soluble guanylyl cyclase.

Roger S, Paysant J, Badier-Commander C, Cordi A, Verbeuren TJ, Félétou M.

Vascul Pharmacol. 2010 Nov-Dec;53(5-6):281-7. doi: 10.1016/j.vph.2010.09.008. Epub 2010 Oct 7.

PMID:
20933607
2.

Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure.

Tamargo J, Duarte J, Caballero R, Delpón E.

Curr Opin Investig Drugs. 2010 Sep;11(9):1039-47.

PMID:
20730699
3.

A G(i) -independent mechanism mediating Akt phosphorylation in platelets.

Xiang B, Zhang G, Liu J, Morris AJ, Smyth SS, Gartner TK, Li Z.

J Thromb Haemost. 2010 Sep;8(9):2032-41. doi: 10.1111/j.1538-7836.2010.03969.x.

4.

Nitric oxide-sensitive guanylyl cyclase is the only nitric oxide receptor mediating platelet inhibition.

Dangel O, Mergia E, Karlisch K, Groneberg D, Koesling D, Friebe A.

J Thromb Haemost. 2010 Jun;8(6):1343-52. doi: 10.1111/j.1538-7836.2010.03806.x. Epub 2010 Feb 11.

5.

The role of superoxide anion in the inhibitory effect of SIN-1 in thrombin-activated human platelet adhesion.

Cardoso MH, Morganti RP, Lilla S, Murad F, De Nucci G, Antunes E, Marcondes S.

Eur J Pharmacol. 2010 Feb 10;627(1-3):229-34. doi: 10.1016/j.ejphar.2009.10.060. Epub 2009 Nov 4.

PMID:
19895807
6.

Nitric oxide inhibits platelet adhesion to collagen through cGMP-dependent and independent mechanisms: the potential role for S-nitrosylation.

Irwin C, Roberts W, Naseem KM.

Platelets. 2009 Nov;20(7):478-86. doi: 10.3109/09537100903159375.

PMID:
19852686
7.

The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models.

Friebe A, Koesling D.

Nitric Oxide. 2009 Nov-Dec;21(3-4):149-56. doi: 10.1016/j.niox.2009.07.004. Epub 2009 Jul 25. Review.

PMID:
19635579
8.

Measuring blood pressure in mice using volume pressure recording, a tail-cuff method.

Daugherty A, Rateri D, Hong L, Balakrishnan A.

J Vis Exp. 2009 May 15;(27). pii: 1291. doi: 10.3791/1291.

9.

Discovery of the nitric oxide signaling pathway and targets for drug development.

Bryan NS, Bian K, Murad F.

Front Biosci (Landmark Ed). 2009 Jan 1;14:1-18. Review.

PMID:
19273051
10.

cGMP regulated protein kinases (cGK).

Hofmann F, Bernhard D, Lukowski R, Weinmeister P.

Handb Exp Pharmacol. 2009;(191):137-62. doi: 10.1007/978-3-540-68964-5_8. Review.

PMID:
19089329
11.

Signaling-mediated functional activation of inducible nitric-oxide synthase and its role in stimulating platelet activation.

Marjanovic JA, Stojanovic A, Brovkovych VM, Skidgel RA, Du X.

J Biol Chem. 2008 Oct 24;283(43):28827-34. doi: 10.1074/jbc.M801646200. Epub 2008 Aug 27.

12.

NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity.

Gambaryan S, Kobsar A, Hartmann S, Birschmann I, Kuhlencordt PJ, Müller-Esterl W, Lohmann SM, Walter U.

J Thromb Haemost. 2008 Aug;6(8):1376-84. doi: 10.1111/j.1538-7836.2008.03014.x. Epub 2008 May 14.

13.

The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation.

Yin H, Stojanovic A, Hay N, Du X.

Blood. 2008 Jan 15;111(2):658-65. Epub 2007 Oct 3.

14.

Nitric oxide regulation of protein trafficking in the cardiovascular system.

Lowenstein CJ.

Cardiovasc Res. 2007 Jul 15;75(2):240-6. Epub 2007 Apr 3. Review.

15.

Fatal gastrointestinal obstruction and hypertension in mice lacking nitric oxide-sensitive guanylyl cyclase.

Friebe A, Mergia E, Dangel O, Lange A, Koesling D.

Proc Natl Acad Sci U S A. 2007 May 1;104(18):7699-704. Epub 2007 Apr 23.

16.

Endobrevin/VAMP-8 is the primary v-SNARE for the platelet release reaction.

Ren Q, Barber HK, Crawford GL, Karim ZA, Zhao C, Choi W, Wang CC, Hong W, Whiteheart SW.

Mol Biol Cell. 2007 Jan;18(1):24-33. Epub 2006 Oct 25.

17.

Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular system.

Mergia E, Friebe A, Dangel O, Russwurm M, Koesling D.

J Clin Invest. 2006 Jun;116(6):1731-7. Epub 2006 May 4.

18.

A phosphoinositide 3-kinase-AKT-nitric oxide-cGMP signaling pathway in stimulating platelet secretion and aggregation.

Stojanovic A, Marjanovic JA, Brovkovych VM, Peng X, Hay N, Skidgel RA, Du X.

J Biol Chem. 2006 Jun 16;281(24):16333-9. Epub 2006 Apr 13.

19.

Cyclic GMP-independent mechanisms contribute to the inhibition of platelet adhesion by nitric oxide donor: a role for alpha-actinin nitration.

Marcondes S, Cardoso MH, Morganti RP, Thomazzi SM, Lilla S, Murad F, De Nucci G, Antunes E.

Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3434-9. Epub 2006 Feb 21.

20.

Phorbol ester mediated activation of inducible nitric oxide synthase results in platelet profilin nitration.

Kasina S, Wasia R, Fasim A, Radhika KV, Singh SS.

Nitric Oxide. 2006 Feb;14(1):65-71. Epub 2005 Nov 8. Erratum in: Nitric Oxide. 2007 Mar;16(2):313.

PMID:
16288977

Supplemental Content

Support Center